Autonomix Medical raises $4.9M via warrant exercise, issues Series E warrants

Autonomix Medical, Inc.

Gross proceeds ~$4.9M from exercise of 857,462 shares at $5.75 per share; close expected Aug 26, 2026.
Issues Series E-1 and E-2 warrants for 535,913 shares each at $6.25 strike, 5-year term, exercisable upon issuance.
Maxim Group LLC acted as financial advisor; cash fee equal to 7.0% of proceeds plus up to $15,000 expenses.
E-2 warrants carry Black-Scholes redemption rights in fundamental transactions; E-1 warrants do not.
Registration statement for New Warrant Shares resale to be filed within 15 days, effective within 45 days.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.